Balsm Alofoq Medical Company

Balsm Alofoq Medical Company

TTADAWUL:9620
22.00
SAR
0.00
(0.00%)
60.00MMarket Cap
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
7.21
7.94
8.15
- -
Basic EPS, GAAP
1.66
1.91
0.79
- -
Free Cash Flow per Basic Share
-0.7
2.11
-2.84
- -
Dividend per Share
0.38
1.2
- -
- -
Book Value per Share
5.76
11.57
12.36
12.68
Tangible Book Value per Share
5.76
11.57
12.36
12.68
Basic Weighted Avg Shares
3
3
3
3
Sales/Revenue/Turnover
18
20
20
- -
Operating Margin (%)
24.39
26.44
13.05
- -
Depreciation Expense
1
1
1
- -
Net Income, GAAP
4
5
2
- -
Effective Tax Rate (%)
2.27
5.24
20.05
- -
Profit Margin (%)
23.08
24.07
9.66
- -
Working Capital
4
20
19
19
LT Debt
2
1
1
3
Total Equity
14
29
31
32
Return on Invested Capital (%)
- -
19.14
6.43
- -
Return on Capital (%)
- -
20.82
6.56
- -
Return on Common Equity (%)
- -
22.08
6.58
- -

Capital Structure

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
96
68
60

Working Capital

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
23
21
21
Cash, Cash Equivalents & STI
18
11
13
Accounts Receivable, Net
- -
1
1
Inventories
3
4
3
Total Current Liabilities
1
2
3
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
6.83%
Free Cash Flow
- -
- -
-234.6%
Net Income, GAAP
- -
- -
-58.84%
Sales/Revenue/Turnover
- -
- -
2.62%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
20
2025
- -
- -
20
2026
- -
- -
- -

Semi-annual Earnings Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1.91
2025
- -
- -
0.79
2026
- -
- -
- -

Semi-annual Dividends Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1.2
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Rami Khamis Abdullah Al-Harbi
Full Time Employees
81
Sector
Health services
Industry
Medical/Nursing services
Address
Qassim King Khalid Road Buraydah QA Saudi Arabia 52385
IPO Date
Dec 16, 2024
Business
Balsm Alofoq Medical Company is a healthcare service provider based in Buraydah, Kingdom of Saudi Arabia, founded in 2012. The company operates specialized clinics offering various medical specialties including general medicine, family medicine, pediatrics, obstetrics and gynecology, dentistry, ophthalmology, dermatology and cosmetic medicine, orthopedics, and rheumatology. It also supplies medical, administrative, and technical personnel such as doctors, specialists, nurses, technicians, and workers to hospitals and medical centers. Additionally, Balsm Alofoq provides hospital and medical center operation and management services, training programs, and modern medical periodicals. The company engages in the sale, maintenance, and supply of medical devices, equipment, consumables, surgical instruments, preventive and sterilization products, medical gloves, protective masks and clothing, medical solutions, laboratory raw materials, and other medical supplies. It also delivers technical and consulting support services to medical institutions in Saudi Arabia. Recent major developments include a strategic expansion plan marked by the signing of a SAR 1.2 million contract with Wadan Medical Co. to purchase medical devices, equipment, and supplies for a new branch in Al Rass city in the Al Qassim region. This contract supports the establishment of specialized clinics and is expected to generate positive financial impact after operational licensing. The company also secured a 10-year lease for premises in Al Rass worth SAR 2.16 million for this new branch. Furthermore, Balsm Alofoq announced a 100% capital increase by bonus shares, doubling its capital from SAR 12.5 million to SAR 25 million, aimed at bolstering strategic growth and expanding financial capacity. These moves reflect an ongoing focus on geographical expansion and strengthening operational infrastructure within Saudi Arabia. Balsm Alofoq Medical Company's core business segments include healthcare services through clinics, supply of medical and administrative personnel to medical institutions, hospital and medical center management services, sale and after-sales support of medical equipment and supplies, and professional training and consulting services for medical institutions. The company serves healthcare providers and patients primarily within the Kingdom of Saudi Arabia, positioning itself as an integrated service provider in the regional medical sector. Its comprehensive approach encompassing service delivery, personnel supply, equipment sales, and technical support underpins its market presence. In summary, Balsm Alofoq Medical Company is a multifaceted medical services and supplies provider headquartered in Buraydah, Saudi Arabia, focusing on specialized clinical services, personnel supply, medical equipment sales, and healthcare management. Since 2024, it has notably expanded through new branch development in the Al Qassim region and a significant capital increase to support growth strategies, reinforcing its commitment to enhancing healthcare service infrastructure within Saudi Arabia. These efforts underline the company's strategic ambitions in the regional healthcare sector.